Estimates indicate that the global morbidity gap is expanding, with individuals spending a greater proportion of life in poor health.

Shortages in the rheumatologist workforce are projected across non-metropolitan areas, the south, and several US states through 2037.

Higher general physician knowledge is associated with a lower use of low-value medical services for older Medicare patients.

Echocardiography showed elevated myocardial dysfunction rates in patients with psoriasis, regardless of disease severity.

Oral microbiome alterations are linked to symptomatic hand osteoarthritis and correlate with gut microbiome dysbiosis.

Adults with autoimmune rheumatic diseases commonly experience chronic overlapping pain conditions despite ongoing anti-inflammatory treatment.

Higher body mass index in patients with knee osteoarthritis is associated with increased health care utilization and annual costs.

Central sensitization in patients with psoriatic arthritis is independently predicted by depression, poor sleep quality, and neuropathic pain.

JAK inhibitor initiation timing relative to RZV administration can affect early antibody response and arthritis control in patients with RA.

An external FDA advisory panel voted to allow specialized pharmacies to produce and sell four previously banned peptide treatments.

Nonserious infection risk in rheumatoid arthritis is similar across treatment classes after adjustment for clinical and seasonal factors.

Opioid prescribing trends decreased between 2010 and 2024, with variations observed across duration of use and prescriber specialty.